Xalkori 200 mg Gélules Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

xalkori 200 mg gélules

pfizer ag - crizotinibum - gélules - crizotinibum 200 mg, silica colloidalis anhydrica, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a corresp. natrium 0.84 mg, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - onkologikum - synthetika

Xalkori 250 mg Gélules Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

xalkori 250 mg gélules

pfizer ag - crizotinibum - gélules - crizotinibum 250 mg, silica colloidalis anhydrica, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a corresp. natrium 1.05 mg, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - onkologikum - synthetika

Oxycodon-Mepha retard 5 mg Retardtabletten Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

oxycodon-mepha retard 5 mg retardtabletten

mepha pharma ag - oxycodoni hydrochloridum - retardtabletten - oxycodoni hydrochloridum 5 mg, lactosum monohydricum de 31,6 mg, hypromellosum, povidonum k 30, acide stearicum, magnésium stearas, de la silice colloidalis anhydrica, Überzug: poly(alcool vinylicus), e 171, macrogolum 3350, talc, e 132, e 172 (jaune), pour compresso de la brume. - narcotique analgésique - synthetika

Oxycodon-Mepha retard 10 mg Retardtabletten Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

oxycodon-mepha retard 10 mg retardtabletten

mepha pharma ag - oxycodoni hydrochloridum - retardtabletten - oxycodoni hydrochloridum 10 mg, lactosum monohydricum 63.2 mg, hypromellosum, povidonum k 30, acide stearicum, magnésium stearas, de la silice colloidalis anhydrica, Überzug: e 171, hypromellosum, macrogolum 400, polysorbatum 80, pour compresso de la brume. - narcotique analgésique - synthetika

Oxycodon-Mepha retard 20 mg Retardtabletten Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

oxycodon-mepha retard 20 mg retardtabletten

mepha pharma ag - oxycodoni hydrochloridum - retardtabletten - oxycodoni hydrochloridum 20 mg, lactosum monohydricum de 31,6 mg, hypromellosum, povidonum k 30, acide stearicum, magnésium stearas, de la silice colloidalis anhydrica, Überzug: poly(alcool vinylicus), e 171, macrogolum 3350, talc, e 172 (rouge), pour compresso de la brume. - narcotique analgésique - synthetika

Oxycodon-Mepha retard 40 mg Retardtabletten Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

oxycodon-mepha retard 40 mg retardtabletten

mepha pharma ag - oxycodoni hydrochloridum - retardtabletten - oxycodoni hydrochloridum 40 mg, lactosum monohydricum de 31,6 mg, hypromellosum, povidonum k 30, acide stearicum, magnésium stearas, de la silice colloidalis anhydrica, Überzug: poly(alcool vinylicus), e 171, macrogolum 3350, talc, e 172 (jaune), pour compresso de la brume. - narcotique analgésique - synthetika

Oxycodon-Mepha retard 80 mg Retardtabletten Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

oxycodon-mepha retard 80 mg retardtabletten

mepha pharma ag - oxycodoni hydrochloridum - retardtabletten - oxycodoni hydrochloridum 80 mg, lactosum monohydricum 63.2 mg, hypromellosum, povidonum k 30, acide stearicum, magnésium stearas, de la silice colloidalis anhydrica, Überzug: poly(alcool vinylicus), macrogolum 3350, talc, e 171, e 132, e 172 (jaune), pour compresso de la brume. - narcotique analgésique - synthetika

Ibrance 75 mg Gélules Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

ibrance 75 mg gélules

pfizer ag - palbociclibum - gélules - palbociclibum 75 mg, cellulosum microcristallinum, lactosum monohydricum 55.775 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.28 mg. - le cancer du sein - synthetika

Ibrance 100 mg Gélules Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

ibrance 100 mg gélules

pfizer ag - palbociclibum - gélules - palbociclibum 100 mg, cellulosum microcristallinum, lactosum monohydricum 74.367 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.71 mg. - le cancer du sein - synthetika

Ibrance 125 mg Gélules Schweiz - franska - Swissmedic (Swiss Agency for Therapeutic Products)

ibrance 125 mg gélules

pfizer ag - palbociclibum - gélules - palbociclibum 125 mg, cellulosum microcristallinum, lactosum monohydricum 92.958 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 2.13 mg. - le cancer du sein - synthetika